HealthLeaders Media August 15, 2022
The New York health system is looking for 1 million patients to participate in a program aimed at developing genetics-based precision medicine treatments and new therapies.
The Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai are looking for 1 million patients to participate in a large-scale human genome sequencing project.
The five-year project, launched in a partnership with Regeneron, aims to provide researchers with data that will help in the development of genetics-based precision medicine treatments and new therapies.
“For decades, we have hoped that genetics would offer doctors the blueprints to each patient’s unique health care needs,” Alexander W. Charney, MD, PhD, an associate professor of psychiatry, genetics, and genomic sciences at the Icahn...
Today's Sponsors
Today's Sponsor